From one target to many: how high‑plex ddPCR is changing CGT from development to analytics

“ddPCR has the potential to advance research that may ultimately improve patient outcomes, and that is the key thing.”

Lauren Coyle, Editor, BioInsights, speaks with Christian Overgaard, Senior Field Application Scientist, Bio‑Rad Laboratories, about the technical and practical evolution of droplet digital PCR (ddPCR) and high‑plex multiplexing, covering assay design challenges, vector integration analysis, biodistribution studies, and the emerging role of digital PCR in cell and gene therapy characterization and clinical development.

Please enter your email to access content Read now